Patanella AK et al. investigated the differential impact of BDNF and IL-6 on cognitive impairment and showed that low BDNF and high IL-6 levels are associated with poor performance in cognitive tasks in patients with relapsing-remitting multiple sclerosis. This evidence concerns the gene IL6 and relapsing-remitting multiple sclerosis.